Getting drugs into the brain is a bit of a holy grail, but researchers at Johns Hopkins University believe that they are a step closer with nanoparticles that can penetrate into the brain, potentially preventing recurrence of cancer after surgery by destroying any remaining tumor cells.
Researchers at the Harvard-affiliated McLean Hospital are taking a cue from the body's natural delivery method to get drugs across the blood-brain barrier.
Angiochem will work with GlaxoSmithKline ($GSK) on creating new treatments that can cross the blood-brain barrier.
Scientists are seeking health department clearance in India to begin testing a rabies treatment in humans that uses silver nanoparticles to deliver itself to the brain. The Times of India reports on
For years now, scientists have touted the enormous promise of using RNAi treatments to turn off bad genes that cause disease, but delivering the drugs effectively to their target cells, particularly
Shire is zipping ahead with clinical research of pump implants in the spine, potentially overcoming a natural hurdle to delivering its enzyme-replacement drug Elaprase into the brains of patients
European biotech NeuroVive and to-BBB technologies have found funds for a novel stroke therapy. Eurostars, a program that funds business activity in Europe, has awarded €500,000 to each of the
Columbia University engineers might have rekindled some faith in using ultrasound pulses to open the blood-brain barrier for drugs to reach targets in the brain. While ultrasound pulses were cast off
Another set of researchers are knocking on the door of the blood-brain barrier , trying to get at the prize inside of better treatments for Alzheimer's, multiple sclerosis and cancers of the central
The blood-brain barrier is nature's way of making sure only authorized personnel enter our body's command center, much to the frustration of drug developers who would love to storm the gates and